Lucile Mollet and her team have been working on medical cannabis for several years. They are collaborating with the company Overseed and the CHU d'Orléans on preclinical and clinical work to study various therapeutic indications for cannabis.

Indeed, medical cannabis should be authorized in France and reimbursed by the health insurance system (with a secure prescription) from January 1, 2025.

To find out more, click here.